Dr. Beth M. Beadle, MD

Dr. Beadle practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Beadle's NPI, 1619116142, was assigned on February 6, 2009. Dr. Beadle graduated from Feinberg School of Medicine in 2004. Dr. Beadle's California license number on file is C143707.

Dr. Beadle's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Beadle's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Beadle is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Beadle to 1 more hospital and 1 medical group, each named with a free account. Dr. Beadle's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beadle practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Beadle's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Beadle is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Beadle's licenses on file in 2 states: California and Texas.

Dmand AI lists head & neck cancer radiation among the conditions Dr. Beadle treats.

CMS data shows 1,773 Medicare services from Dr. Beadle across 15 procedure codes in 2024, for 255 Medicare patients. Medicare paid $119,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 255 Medicare patients who saw Dr. Beadle in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beadle's median patient age at 65, with 35% women.

In 2024, Dr. Beadle wrote 204 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 171 of them, across 5 drugs with 11 or more claims each, at $2,611 in total drug cost. In 2023, CMS named 117 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Beadle for performance year 2024, reported as part of a group. Dr. Beadle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 172 papers to Dr. Beadle, published from 2008 to 2025. 2017 was the busiest year, with 16. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Radiotherapy Planning, Computer-Assisted. Dr. Beadle has published most often in Int J Radiat Oncol Biol Phys. Dr. Beadle's most frequent co-authors are Clifton David Fuller, MD, David I. Rosenthal, MD and William H. Morrison, MD.

Dmand AI links Dr. Beadle to 3 clinical trials, 2 of them phase 2/3 studies. 1 is still active or recruiting. Conditions studied include Hypopharyngeal Neoplasms, Oropharyngeal Neoplasms and Radiodermatitis. National Cancer Institute (NCI) sponsors the most, 2.

Dr. Beadle graduated from Feinberg School of Medicine in 2004.

Dr. Beadle is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.